CVS Health Reports Strong Q4 Performance

CVS Health Corporation announced a significant achievement in its fourth-quarter financial results for fiscal 2024, with revenues reaching $97.7 billion. This marks a 4.2% increase compared to the previous year, exceeding analysts' expectations. Despite a 17% drop in diluted earnings per share to $1.30 and a 29% decrease in operating income to $2.3 billion, the company remains optimistic about its future.

2025 Financial Outlook

Looking ahead, CVS Health has set its sights on a promising 2025, with projected diluted EPS between $4.58 to $4.83 and an anticipated cash flow from operations of approximately $6.5 billion. CEO David Joyner emphasized the company's commitment to overcoming industry challenges and enhancing consumer care, which has led to a 9.15% surge in the company's shares during premarket trading, reaching $60.03 at 6:36 am ET.